IVIGの世界市場（～2026年）

• 英文タイトル：Global IVIG Market Insights and Forecast to 2026

• レポートコード：MRC2-11QY01860 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、151ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料はIVIGのグローバル市場について調査・分析したレポートです。種類別（注射、凍結乾燥粉末）市場規模、用途別（多発性硬化症（MS）、重症筋無力症（MG）、多巣性運動ニューロパチー（MMN）、多巣性後天性感覚運動ニューロパチー（MADSAM）、皮膚筋炎、多巣性運動ニューロシス）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別IVIGの競争状況、市場シェア ・世界のIVIG市場：種類別市場規模 2015年-2020年（注射、凍結乾燥粉末） ・世界のIVIG市場：種類別市場規模予測 2021年-2026年（注射、凍結乾燥粉末） ・世界のIVIG市場：用途別市場規模 2015年-2020年（多発性硬化症（MS）、重症筋無力症（MG）、多巣性運動ニューロパチー（MMN）、多巣性後天性感覚運動ニューロパチー（MADSAM）、皮膚筋炎、多巣性運動ニューロシス） ・世界のIVIG市場：用途別市場規模予測 2021年-2026年（多発性硬化症（MS）、重症筋無力症（MG）、多巣性運動ニューロパチー（MMN）、多巣性後天性感覚運動ニューロパチー（MADSAM）、皮膚筋炎、多巣性運動ニューロシス） ・北米のIVIG市場分析：米国、カナダ ・ヨーロッパのIVIG市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのIVIG市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のIVIG市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのIVIG市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Green Cross、BSV、Hualan Bio、RAAS、YUAN DA SHUYANG、Kangbao Bio、Tiantan Bio、Taibang Bio、Weiguang Bio、SIBP、TONROL、RUIDE Bio、BOYA Bio、RUIDE Bio、Xinxing Medicine、Weilun Bio、WIBP ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Market Analysis and Insights: Global IVIG Market
The global IVIG market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global IVIG Scope and Market Size
IVIG market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global IVIG market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the IVIG market is segmented into
Injection
Lyophilized Powder

Segment by Application, the IVIG market is segmented into
Multiple Sclerosis (MS)
Myasthenia Gravis (MG)
Multifocal Motor Neuropathy (MMN)
Multifocal Acquired Sensory and Motor Neuropathy (MADSAM)
Dermatomyositis
Polymyositis

Regional and Country-level Analysis
The IVIG market is analysed and market size information is provided by regions (countries).
The key regions covered in the IVIG market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and IVIG Market Share Analysis
IVIG market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in IVIG business, the date to enter into the IVIG market, IVIG product introduction, recent developments, etc.

The major vendors covered:
Green Cross
BSV
Hualan Bio
RAAS
YUAN DA SHUYANG
Kangbao Bio
Tiantan Bio
Taibang Bio
Weiguang Bio
SIBP
TONROL
RUIDE Bio
BOYA Bio
RUIDE Bio
Xinxing Medicine
Weilun Bio
WIBP

レポート目次

---

1 Study Coverage
1.1 IVIG Product Introduction
1.2 Market Segments
1.3 Key IVIG Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global IVIG Market Size Growth Rate by Type
1.4.2 Injection
1.4.3 Lyophilized Powder
1.5 Market by Application
1.5.1 Global IVIG Market Size Growth Rate by Application
1.5.2 Multiple Sclerosis (MS)
1.5.3 Myasthenia Gravis (MG)
1.5.4 Multifocal Motor Neuropathy (MMN)
1.5.5 Multifocal Acquired Sensory and Motor Neuropathy (MADSAM)
1.5.6 Dermatomyositis
1.5.7 Polymyositis
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global IVIG Market Size, Estimates and Forecasts
2.1.1 Global IVIG Revenue 2015-2026
2.1.2 Global IVIG Sales 2015-2026
2.2 Global IVIG, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global IVIG Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global IVIG Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global IVIG Competitor Landscape by Players
3.1 IVIG Sales by Manufacturers
3.1.1 IVIG Sales by Manufacturers (2015-2020)
3.1.2 IVIG Sales Market Share by Manufacturers (2015-2020)
3.2 IVIG Revenue by Manufacturers
3.2.1 IVIG Revenue by Manufacturers (2015-2020)
3.2.2 IVIG Revenue Share by Manufacturers (2015-2020)
3.2.3 Global IVIG Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by IVIG Revenue in 2019
3.2.5 Global IVIG Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 IVIG Price by Manufacturers
3.4 IVIG Manufacturing Base Distribution, Product Types
3.4.1 IVIG Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers IVIG Product Type
3.4.3 Date of International Manufacturers Enter into IVIG Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global IVIG Market Size by Type (2015-2020)
4.1.1 Global IVIG Sales by Type (2015-2020)
4.1.2 Global IVIG Revenue by Type (2015-2020)
4.1.3 IVIG Average Selling Price (ASP) by Type (2015-2026)
4.2 Global IVIG Market Size Forecast by Type (2021-2026)
4.2.1 Global IVIG Sales Forecast by Type (2021-2026)
4.2.2 Global IVIG Revenue Forecast by Type (2021-2026)
4.2.3 IVIG Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global IVIG Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global IVIG Market Size by Application (2015-2020)
5.1.1 Global IVIG Sales by Application (2015-2020)
5.1.2 Global IVIG Revenue by Application (2015-2020)
5.1.3 IVIG Price by Application (2015-2020)
5.2 IVIG Market Size Forecast by Application (2021-2026)
5.2.1 Global IVIG Sales Forecast by Application (2021-2026)
5.2.2 Global IVIG Revenue Forecast by Application (2021-2026)
5.2.3 Global IVIG Price Forecast by Application (2021-2026)

6 North America
6.1 North America IVIG by Country
6.1.1 North America IVIG Sales by Country
6.1.2 North America IVIG Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America IVIG Market Facts & Figures by Type
6.3 North America IVIG Market Facts & Figures by Application

7 Europe
7.1 Europe IVIG by Country
7.1.1 Europe IVIG Sales by Country
7.1.2 Europe IVIG Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe IVIG Market Facts & Figures by Type
7.3 Europe IVIG Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific IVIG by Region
8.1.1 Asia Pacific IVIG Sales by Region
8.1.2 Asia Pacific IVIG Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific IVIG Market Facts & Figures by Type
8.3 Asia Pacific IVIG Market Facts & Figures by Application

9 Latin America
9.1 Latin America IVIG by Country
9.1.1 Latin America IVIG Sales by Country
9.1.2 Latin America IVIG Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America IVIG Market Facts & Figures by Type
9.3 Central & South America IVIG Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa IVIG by Country
10.1.1 Middle East and Africa IVIG Sales by Country
10.1.2 Middle East and Africa IVIG Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa IVIG Market Facts & Figures by Type
10.3 Middle East and Africa IVIG Market Facts & Figures by Application

11 Company Profiles
11.1 Green Cross
11.1.1 Green Cross Corporation Information
11.1.2 Green Cross Description and Business Overview
11.1.3 Green Cross Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Green Cross IVIG Products Offered
11.1.5 Green Cross Related Developments
11.2 BSV
11.2.1 BSV Corporation Information
11.2.2 BSV Description and Business Overview
11.2.3 BSV Sales, Revenue and Gross Margin (2015-2020)
11.2.4 BSV IVIG Products Offered
11.2.5 BSV Related Developments
11.3 Hualan Bio
11.3.1 Hualan Bio Corporation Information
11.3.2 Hualan Bio Description and Business Overview
11.3.3 Hualan Bio Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Hualan Bio IVIG Products Offered
11.3.5 Hualan Bio Related Developments
11.4 RAAS
11.4.1 RAAS Corporation Information
11.4.2 RAAS Description and Business Overview
11.4.3 RAAS Sales, Revenue and Gross Margin (2015-2020)
11.4.4 RAAS IVIG Products Offered
11.4.5 RAAS Related Developments
11.5 YUAN DA SHUYANG
11.5.1 YUAN DA SHUYANG Corporation Information
11.5.2 YUAN DA SHUYANG Description and Business Overview
11.5.3 YUAN DA SHUYANG Sales, Revenue and Gross Margin (2015-2020)
11.5.4 YUAN DA SHUYANG IVIG Products Offered
11.5.5 YUAN DA SHUYANG Related Developments
11.6 Kangbao Bio
11.6.1 Kangbao Bio Corporation Information
11.6.2 Kangbao Bio Description and Business Overview
11.6.3 Kangbao Bio Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Kangbao Bio IVIG Products Offered
11.6.5 Kangbao Bio Related Developments
11.7 Tiantan Bio
11.7.1 Tiantan Bio Corporation Information
11.7.2 Tiantan Bio Description and Business Overview
11.7.3 Tiantan Bio Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Tiantan Bio IVIG Products Offered
11.7.5 Tiantan Bio Related Developments
11.8 Taibang Bio
11.8.1 Taibang Bio Corporation Information
11.8.2 Taibang Bio Description and Business Overview
11.8.3 Taibang Bio Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Taibang Bio IVIG Products Offered
11.8.5 Taibang Bio Related Developments
11.9 Weiguang Bio
11.9.1 Weiguang Bio Corporation Information
11.9.2 Weiguang Bio Description and Business Overview
11.9.3 Weiguang Bio Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Weiguang Bio IVIG Products Offered
11.9.5 Weiguang Bio Related Developments
11.10 SIBP
11.10.1 SIBP Corporation Information
11.10.2 SIBP Description and Business Overview
11.10.3 SIBP Sales, Revenue and Gross Margin (2015-2020)
11.10.4 SIBP IVIG Products Offered
11.10.5 SIBP Related Developments
11.1 Green Cross
11.1.1 Green Cross Corporation Information
11.1.2 Green Cross Description and Business Overview
11.1.3 Green Cross Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Green Cross IVIG Products Offered
11.1.5 Green Cross Related Developments
11.12 RUIDE Bio
11.12.1 RUIDE Bio Corporation Information
11.12.2 RUIDE Bio Description and Business Overview
11.12.3 RUIDE Bio Sales, Revenue and Gross Margin (2015-2020)
11.12.4 RUIDE Bio Products Offered
11.12.5 RUIDE Bio Related Developments
11.13 BOYA Bio
11.13.1 BOYA Bio Corporation Information
11.13.2 BOYA Bio Description and Business Overview
11.13.3 BOYA Bio Sales, Revenue and Gross Margin (2015-2020)
11.13.4 BOYA Bio Products Offered
11.13.5 BOYA Bio Related Developments
11.14 RUIDE Bio
11.14.1 RUIDE Bio Corporation Information
11.14.2 RUIDE Bio Description and Business Overview
11.14.3 RUIDE Bio Sales, Revenue and Gross Margin (2015-2020)
11.14.4 RUIDE Bio Products Offered
11.14.5 RUIDE Bio Related Developments
11.15 Xinxing Medicine
11.15.1 Xinxing Medicine Corporation Information
11.15.2 Xinxing Medicine Description and Business Overview
11.15.3 Xinxing Medicine Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Xinxing Medicine Products Offered
11.15.5 Xinxing Medicine Related Developments
11.16 Weilun Bio
11.16.1 Weilun Bio Corporation Information
11.16.2 Weilun Bio Description and Business Overview
11.16.3 Weilun Bio Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Weilun Bio Products Offered
11.16.5 Weilun Bio Related Developments
11.17 WIBP
11.17.1 WIBP Corporation Information
11.17.2 WIBP Description and Business Overview
11.17.3 WIBP Sales, Revenue and Gross Margin (2015-2020)
11.17.4 WIBP Products Offered
11.17.5 WIBP Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 IVIG Market Estimates and Projections by Region
12.1.1 Global IVIG Sales Forecast by Regions 2021-2026
12.1.2 Global IVIG Revenue Forecast by Regions 2021-2026
12.2 North America IVIG Market Size Forecast (2021-2026)
12.2.1 North America: IVIG Sales Forecast (2021-2026)
12.2.2 North America: IVIG Revenue Forecast (2021-2026)
12.2.3 North America: IVIG Market Size Forecast by Country (2021-2026)
12.3 Europe IVIG Market Size Forecast (2021-2026)
12.3.1 Europe: IVIG Sales Forecast (2021-2026)
12.3.2 Europe: IVIG Revenue Forecast (2021-2026)
12.3.3 Europe: IVIG Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific IVIG Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: IVIG Sales Forecast (2021-2026)
12.4.2 Asia Pacific: IVIG Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: IVIG Market Size Forecast by Region (2021-2026)
12.5 Latin America IVIG Market Size Forecast (2021-2026)
12.5.1 Latin America: IVIG Sales Forecast (2021-2026)
12.5.2 Latin America: IVIG Revenue Forecast (2021-2026)
12.5.3 Latin America: IVIG Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa IVIG Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: IVIG Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: IVIG Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: IVIG Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key IVIG Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 IVIG Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. IVIG Market Segments
Table 2. Ranking of Global Top IVIG Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global IVIG Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Injection
Table 5. Major Manufacturers of Lyophilized Powder
Table 6. Global IVIG Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global IVIG Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global IVIG Sales by Regions 2015-2020 (K Units)
Table 9. Global IVIG Sales Market Share by Regions (2015-2020)
Table 10. Global IVIG Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global IVIG Sales by Manufacturers (2015-2020) (K Units)
Table 12. Global IVIG Sales Share by Manufacturers (2015-2020)
Table 13. Global IVIG Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global IVIG by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in IVIG as of 2019)
Table 15. IVIG Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. IVIG Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers IVIG Price (2015-2020) (USD/Unit)
Table 18. IVIG Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers IVIG Product Type
Table 20. Date of International Manufacturers Enter into IVIG Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global IVIG Sales by Type (2015-2020) (K Units)
Table 23. Global IVIG Sales Share by Type (2015-2020)
Table 24. Global IVIG Revenue by Type (2015-2020) (US$ Million)
Table 25. Global IVIG Revenue Share by Type (2015-2020)
Table 26. IVIG Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 27. Global IVIG Sales by Application (2015-2020) (K Units)
Table 28. Global IVIG Sales Share by Application (2015-2020)
Table 29. North America IVIG Sales by Country (2015-2020) (K Units)
Table 30. North America IVIG Sales Market Share by Country (2015-2020)
Table 31. North America IVIG Revenue by Country (2015-2020) (US$ Million)
Table 32. North America IVIG Revenue Market Share by Country (2015-2020)
Table 33. North America IVIG Sales by Type (2015-2020) (K Units)
Table 34. North America IVIG Sales Market Share by Type (2015-2020)
Table 35. North America IVIG Sales by Application (2015-2020) (K Units)
Table 36. North America IVIG Sales Market Share by Application (2015-2020)
Table 37. Europe IVIG Sales by Country (2015-2020) (K Units)
Table 38. Europe IVIG Sales Market Share by Country (2015-2020)
Table 39. Europe IVIG Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe IVIG Revenue Market Share by Country (2015-2020)
Table 41. Europe IVIG Sales by Type (2015-2020) (K Units)
Table 42. Europe IVIG Sales Market Share by Type (2015-2020)
Table 43. Europe IVIG Sales by Application (2015-2020) (K Units)
Table 44. Europe IVIG Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific IVIG Sales by Region (2015-2020) (K Units)
Table 46. Asia Pacific IVIG Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific IVIG Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific IVIG Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific IVIG Sales by Type (2015-2020) (K Units)
Table 50. Asia Pacific IVIG Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific IVIG Sales by Application (2015-2020) (K Units)
Table 52. Asia Pacific IVIG Sales Market Share by Application (2015-2020)
Table 53. Latin America IVIG Sales by Country (2015-2020) (K Units)
Table 54. Latin America IVIG Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa IVIG Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America IVIG Revenue Market Share by Country (2015-2020)
Table 57. Latin America IVIG Sales by Type (2015-2020) (K Units)
Table 58. Latin America IVIG Sales Market Share by Type (2015-2020)
Table 59. Latin America IVIG Sales by Application (2015-2020) (K Units)
Table 60. Latin America IVIG Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa IVIG Sales by Country (2015-2020) (K Units)
Table 62. Middle East and Africa IVIG Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa IVIG Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa IVIG Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa IVIG Sales by Type (2015-2020) (K Units)
Table 66. Middle East and Africa IVIG Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa IVIG Sales by Application (2015-2020) (K Units)
Table 68. Middle East and Africa IVIG Sales Market Share by Application (2015-2020)
Table 69. Green Cross Corporation Information
Table 70. Green Cross Description and Major Businesses
Table 71. Green Cross IVIG Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. Green Cross Product
Table 73. Green Cross Recent Development
Table 74. BSV Corporation Information
Table 75. BSV Description and Major Businesses
Table 76. BSV IVIG Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. BSV Product
Table 78. BSV Recent Development
Table 79. Hualan Bio Corporation Information
Table 80. Hualan Bio Description and Major Businesses
Table 81. Hualan Bio IVIG Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Hualan Bio Product
Table 83. Hualan Bio Recent Development
Table 84. RAAS Corporation Information
Table 85. RAAS Description and Major Businesses
Table 86. RAAS IVIG Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. RAAS Product
Table 88. RAAS Recent Development
Table 89. YUAN DA SHUYANG Corporation Information
Table 90. YUAN DA SHUYANG Description and Major Businesses
Table 91. YUAN DA SHUYANG IVIG Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. YUAN DA SHUYANG Product
Table 93. YUAN DA SHUYANG Recent Development
Table 94. Kangbao Bio Corporation Information
Table 95. Kangbao Bio Description and Major Businesses
Table 96. Kangbao Bio IVIG Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Kangbao Bio Product
Table 98. Kangbao Bio Recent Development
Table 99. Tiantan Bio Corporation Information
Table 100. Tiantan Bio Description and Major Businesses
Table 101. Tiantan Bio IVIG Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Tiantan Bio Product
Table 103. Tiantan Bio Recent Development
Table 104. Taibang Bio Corporation Information
Table 105. Taibang Bio Description and Major Businesses
Table 106. Taibang Bio IVIG Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Taibang Bio Product
Table 108. Taibang Bio Recent Development
Table 109. Weiguang Bio Corporation Information
Table 110. Weiguang Bio Description and Major Businesses
Table 111. Weiguang Bio IVIG Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Weiguang Bio Product
Table 113. Weiguang Bio Recent Development
Table 114. SIBP Corporation Information
Table 115. SIBP Description and Major Businesses
Table 116. SIBP IVIG Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. SIBP Product
Table 118. SIBP Recent Development
Table 119. TONROL Corporation Information
Table 120. TONROL Description and Major Businesses
Table 121. TONROL IVIG Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. TONROL Product
Table 123. TONROL Recent Development
Table 124. RUIDE Bio Corporation Information
Table 125. RUIDE Bio Description and Major Businesses
Table 126. RUIDE Bio IVIG Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 127. RUIDE Bio Product
Table 128. RUIDE Bio Recent Development
Table 129. BOYA Bio Corporation Information
Table 130. BOYA Bio Description and Major Businesses
Table 131. BOYA Bio IVIG Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 132. BOYA Bio Product
Table 133. BOYA Bio Recent Development
Table 134. RUIDE Bio Corporation Information
Table 135. RUIDE Bio Description and Major Businesses
Table 136. RUIDE Bio IVIG Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 137. RUIDE Bio Product
Table 138. RUIDE Bio Recent Development
Table 139. Xinxing Medicine Corporation Information
Table 140. Xinxing Medicine Description and Major Businesses
Table 141. Xinxing Medicine IVIG Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 142. Xinxing Medicine Product
Table 143. Xinxing Medicine Recent Development
Table 144. Weilun Bio Corporation Information
Table 145. Weilun Bio Description and Major Businesses
Table 146. Weilun Bio IVIG Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 147. Weilun Bio Product
Table 148. Weilun Bio Recent Development
Table 149. WIBP Corporation Information
Table 150. WIBP Description and Major Businesses
Table 151. WIBP IVIG Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 152. WIBP Product
Table 153. WIBP Recent Development
Table 154. Global IVIG Sales Forecast by Regions (2021-2026) (K Units)
Table 155. Global IVIG Sales Market Share Forecast by Regions (2021-2026)
Table 156. Global IVIG Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 157. Global IVIG Revenue Market Share Forecast by Regions (2021-2026)
Table 158. North America: IVIG Sales Forecast by Country (2021-2026) (K Units)
Table 159. North America: IVIG Revenue Forecast by Country (2021-2026) (US$ Million)
Table 160. Europe: IVIG Sales Forecast by Country (2021-2026) (K Units)
Table 161. Europe: IVIG Revenue Forecast by Country (2021-2026) (US$ Million)
Table 162. Asia Pacific: IVIG Sales Forecast by Region (2021-2026) (K Units)
Table 163. Asia Pacific: IVIG Revenue Forecast by Region (2021-2026) (US$ Million)
Table 164. Latin America: IVIG Sales Forecast by Country (2021-2026) (K Units)
Table 165. Latin America: IVIG Revenue Forecast by Country (2021-2026) (US$ Million)
Table 166. Middle East and Africa: IVIG Sales Forecast by Country (2021-2026) (K Units)
Table 167. Middle East and Africa: IVIG Revenue Forecast by Country (2021-2026) (US$ Million)
Table 168. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 169. Key Challenges
Table 170. Market Risks
Table 171. Main Points Interviewed from Key IVIG Players
Table 172. IVIG Customers List
Table 173. IVIG Distributors List
Table 174. Research Programs/Design for This Report
Table 175. Key Data Information from Secondary Sources
Table 176. Key Data Information from Primary Sources
List of Figures
Figure 1. IVIG Product Picture
Figure 2. Global IVIG Sales Market Share by Type in 2020 & 2026
Figure 3. Injection Product Picture
Figure 4. Lyophilized Powder Product Picture
Figure 5. Global IVIG Sales Market Share by Application in 2020 & 2026
Figure 6. Multiple Sclerosis (MS)
Figure 7. Myasthenia Gravis (MG)
Figure 8. Multifocal Motor Neuropathy (MMN)
Figure 9. Multifocal Acquired Sensory and Motor Neuropathy (MADSAM)
Figure 10. Dermatomyositis
Figure 11. Polymyositis
Figure 12. IVIG Report Years Considered
Figure 13. Global IVIG Market Size 2015-2026 (US$ Million)
Figure 14. Global IVIG Sales 2015-2026 (K Units)
Figure 15. Global IVIG Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global IVIG Sales Market Share by Region (2015-2020)
Figure 17. Global IVIG Sales Market Share by Region in 2019
Figure 18. Global IVIG Revenue Market Share by Region (2015-2020)
Figure 19. Global IVIG Revenue Market Share by Region in 2019
Figure 20. Global IVIG Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by IVIG Revenue in 2019
Figure 22. IVIG Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global IVIG Sales Market Share by Type (2015-2020)
Figure 24. Global IVIG Sales Market Share by Type in 2019
Figure 25. Global IVIG Revenue Market Share by Type (2015-2020)
Figure 26. Global IVIG Revenue Market Share by Type in 2019
Figure 27. Global IVIG Market Share by Price Range (2015-2020)
Figure 28. Global IVIG Sales Market Share by Application (2015-2020)
Figure 29. Global IVIG Sales Market Share by Application in 2019
Figure 30. Global IVIG Revenue Market Share by Application (2015-2020)
Figure 31. Global IVIG Revenue Market Share by Application in 2019
Figure 32. North America IVIG Sales Growth Rate 2015-2020 (K Units)
Figure 33. North America IVIG Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America IVIG Sales Market Share by Country in 2019
Figure 35. North America IVIG Revenue Market Share by Country in 2019
Figure 36. U.S. IVIG Sales Growth Rate (2015-2020) (K Units)
Figure 37. U.S. IVIG Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada IVIG Sales Growth Rate (2015-2020) (K Units)
Figure 39. Canada IVIG Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America IVIG Market Share by Type in 2019
Figure 41. North America IVIG Market Share by Application in 2019
Figure 42. Europe IVIG Sales Growth Rate 2015-2020 (K Units)
Figure 43. Europe IVIG Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe IVIG Sales Market Share by Country in 2019
Figure 45. Europe IVIG Revenue Market Share by Country in 2019
Figure 46. Germany IVIG Sales Growth Rate (2015-2020) (K Units)
Figure 47. Germany IVIG Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France IVIG Sales Growth Rate (2015-2020) (K Units)
Figure 49. France IVIG Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. IVIG Sales Growth Rate (2015-2020) (K Units)
Figure 51. U.K. IVIG Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy IVIG Sales Growth Rate (2015-2020) (K Units)
Figure 53. Italy IVIG Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia IVIG Sales Growth Rate (2015-2020) (K Units)
Figure 55. Russia IVIG Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe IVIG Market Share by Type in 2019
Figure 57. Europe IVIG Market Share by Application in 2019
Figure 58. Asia Pacific IVIG Sales Growth Rate 2015-2020 (K Units)
Figure 59. Asia Pacific IVIG Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific IVIG Sales Market Share by Region in 2019
Figure 61. Asia Pacific IVIG Revenue Market Share by Region in 2019
Figure 62. China IVIG Sales Growth Rate (2015-2020) (K Units)
Figure 63. China IVIG Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan IVIG Sales Growth Rate (2015-2020) (K Units)
Figure 65. Japan IVIG Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea IVIG Sales Growth Rate (2015-2020) (K Units)
Figure 67. South Korea IVIG Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India IVIG Sales Growth Rate (2015-2020) (K Units)
Figure 69. India IVIG Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia IVIG Sales Growth Rate (2015-2020) (K Units)
Figure 71. Australia IVIG Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan IVIG Sales Growth Rate (2015-2020) (K Units)
Figure 73. Taiwan IVIG Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia IVIG Sales Growth Rate (2015-2020) (K Units)
Figure 75. Indonesia IVIG Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand IVIG Sales Growth Rate (2015-2020) (K Units)
Figure 77. Thailand IVIG Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia IVIG Sales Growth Rate (2015-2020) (K Units)
Figure 79. Malaysia IVIG Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines IVIG Sales Growth Rate (2015-2020) (K Units)
Figure 81. Philippines IVIG Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam IVIG Sales Growth Rate (2015-2020) (K Units)
Figure 83. Vietnam IVIG Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific IVIG Market Share by Type in 2019
Figure 85. Asia Pacific IVIG Market Share by Application in 2019
Figure 86. Latin America IVIG Sales Growth Rate 2015-2020 (K Units)
Figure 87. Latin America IVIG Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America IVIG Sales Market Share by Country in 2019
Figure 89. Latin America IVIG Revenue Market Share by Country in 2019
Figure 90. Mexico IVIG Sales Growth Rate (2015-2020) (K Units)
Figure 91. Mexico IVIG Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil IVIG Sales Growth Rate (2015-2020) (K Units)
Figure 93. Brazil IVIG Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina IVIG Sales Growth Rate (2015-2020) (K Units)
Figure 95. Argentina IVIG Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America IVIG Market Share by Type in 2019
Figure 97. Latin America IVIG Market Share by Application in 2019
Figure 98. Middle East and Africa IVIG Sales Growth Rate 2015-2020 (K Units)
Figure 99. Middle East and Africa IVIG Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa IVIG Sales Market Share by Country in 2019
Figure 101. Middle East and Africa IVIG Revenue Market Share by Country in 2019
Figure 102. Turkey IVIG Sales Growth Rate (2015-2020) (K Units)
Figure 103. Turkey IVIG Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia IVIG Sales Growth Rate (2015-2020) (K Units)
Figure 105. Saudi Arabia IVIG Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E IVIG Sales Growth Rate (2015-2020) (K Units)
Figure 107. U.A.E IVIG Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa IVIG Market Share by Type in 2019
Figure 109. Middle East and Africa IVIG Market Share by Application in 2019
Figure 110. North America IVIG Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 111. North America IVIG Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe IVIG Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. Europe IVIG Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific IVIG Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Asia Pacific IVIG Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America IVIG Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Latin America IVIG Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa IVIG Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 119. Middle East and Africa IVIG Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed

---